ArticleBiological psychiatry global open science2026
Spatial Mapping of Genetic Liability to Psychiatric Disorders in the Adult Human Hippocampus.
Article in Biological psychiatry global open science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mapping Risk for Psychiatric Disorders to Brain Regions Using Spatial Transcriptomics.Biological psychiatry global open science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Common genetic variants associated with psychiatric disorders are enriched in genes with high expression specificity for hippocampal neurons. However, to date, these studies have been based on measures of gene expression from nuclei in liquid suspensions, where information on the precise location of cells within the assayed tissue is lost. Methods: We applied genetically informed spatial mapping of cells for complex traits (gsMAP) to test enrichment of common-variant genetic liability to schizophrenia, bipolar disorder, and major depressive disorder (MDD) in 13 hippocampal subregions according to expression specificity of associated genes using spatial transcriptomic (ST) data from 10 neurotypical adult donors. Then we used cellular deconvolution data from ST spots to perform further gsMAP analyses on cell populations within enriched subregions. Results: Compared with other hippocampal subregions, common-variant liability to schizophrenia, bipolar disorder, and, to a lesser extent, MDD, was significantly enriched in genes with higher expression specificity for the subiculum and neuron-rich areas of the cornu ammonis subfields and dentate gyrus. Within implicated regions, enrichments for schizophrenia and bipolar disorder were pronounced in ST spots containing glutamatergic neurons. Genes with higher expression specificity for the granule cell layer and subgranular zone of the dentate gyrus were more significantly enriched for association with bipolar disorder than for schizophrenia. Conclusions: Our findings support a role for glutamatergic neurons in all major subregions of the hippocampus in mediating common-variant liability to schizophrenia and bipolar disorder and provide evidence for the greater relative importance of the dentate gyrus in bipolar disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.